becton dickinson compani
updat somewhat disappoint multipl headwind outsid
control fx dcb issu led reduc ep outlook remain confid
acceler prospect improv ep growth
stock trade line average ftm price-to-earnings modest
premium con view rel safe choppi care
tape maintain buy pt
focu acceler
deliv fxn growth guidanc impli acceler
driven cont momentum share gain revenu synergi captur
md diagnost growth bd time tender order
new product flu comp necessarili see ton room near-
term upsid feel comfort move part support acceler
full-year like come bottom end fxn growth target
light dcb-relat headwind
exit gross debt/ebitda pay anoth
debt period remain solidli on-track achiev leverag target
end still leav room potenti small tuck-in could
tabl next mo
trim ep forecast increment
fx dcb-relat headwind ep move
assum fxn revenu growth given nt uncertainti around lutonix
btk product recent fda approv time delay type diabet pump
step back share trade ftm ep line histor
average turn haircut rel rang past year
discount larg cap med-tech comp average recent multipl
compress understand given hand nt issu uncertainti around
coupl pipelin project like risk/reward recent pullback given view
management muscl current air pocket deliv improv ep
growth revis pt impli ep line current
multipl ep
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
becton dickinson compani
see compel defens larg cap hold given
abil drive durabl core growth mid-teen ep
growth still support dividend continu success
revenue/cost synergi integr bard
paramount stock move
nopat compound-annual-growth-rate next decad
realiz bcr-relat cost synergi
yr
price multipl ev ebitda
realiz bcr-relat cost synergi
price multipl ev ebitda
price multipl ev
pleas see import disclosur inform page report
becton dickinson compani
financi summari market data
estim valuat
pleas see import disclosur inform page report
becton dickinson compani
pleas see import disclosur inform page report
becton dickinson companyhistor project valuat summarydollar million except per share amount fiscal year end septemb histor earn per flow cash cash flow cash flow per cash net interest free cash add-back sheet metricsreceiv day day day convers interest debt ttm debt ttm valu per jefferi co estim equiti research
becton dickinson compani
pleas see import disclosur inform page report
becton dickinson companyhistor project statement incomedollar million except per share amount fiscal year end septemb histor net product incom expens dividend share share analysisgross research sg ebitda oper incom net growth analysisnet gross research sg oper incom net dilut jefferi co equiti research
becton dickinson compani
becton dickinson co
becton dickinson co global medic technolog compani manufactur sell broad rang medic suppli
devic laboratori equip diagnost product compani oper two busi divis medic life scienc
diagnost bioscienc
becton dickinson co
pt reflect horizon dcf impli ep risk util new product uptak bcr integr
brandon couillard certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
matthew stanton certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
michael koban certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
pleas see import disclosur inform page report
